ATE309354T1 - Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen - Google Patents

Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen

Info

Publication number
ATE309354T1
ATE309354T1 AT00954207T AT00954207T ATE309354T1 AT E309354 T1 ATE309354 T1 AT E309354T1 AT 00954207 T AT00954207 T AT 00954207T AT 00954207 T AT00954207 T AT 00954207T AT E309354 T1 ATE309354 T1 AT E309354T1
Authority
AT
Austria
Prior art keywords
rbt1
replication protein
transcription factor
binding transcription
protein
Prior art date
Application number
AT00954207T
Other languages
English (en)
Inventor
Moulay A Alaoui-Jamali
John Myung-Jae Cho
Original Assignee
Ct For Translational Res In Ca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct For Translational Res In Ca filed Critical Ct For Translational Res In Ca
Application granted granted Critical
Publication of ATE309354T1 publication Critical patent/ATE309354T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00954207T 1999-08-19 2000-08-17 Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen ATE309354T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14947299P 1999-08-19 1999-08-19
PCT/CA2000/000948 WO2001014546A2 (en) 1999-08-19 2000-08-17 Replication protein a binding transcriptional factor (rbt1) and uses thereof

Publications (1)

Publication Number Publication Date
ATE309354T1 true ATE309354T1 (de) 2005-11-15

Family

ID=22530436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954207T ATE309354T1 (de) 1999-08-19 2000-08-17 Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen

Country Status (6)

Country Link
EP (1) EP1206542B1 (de)
AT (1) ATE309354T1 (de)
AU (1) AU6675900A (de)
CA (1) CA2377730A1 (de)
DE (1) DE60023915T2 (de)
WO (1) WO2001014546A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3583797A (en) * 1996-06-28 1998-01-21 Regents Of The University Of California, The Enhancement of cancer cell death
IL131328A0 (en) * 1997-02-28 2001-01-28 Boehringer Ingelhem Pharmaceut Self-regulated apoptosis of inflammatory cells by gene therapy

Also Published As

Publication number Publication date
EP1206542A2 (de) 2002-05-22
WO2001014546A2 (en) 2001-03-01
WO2001014546A3 (en) 2001-11-29
DE60023915T2 (de) 2006-08-10
DE60023915D1 (de) 2005-12-15
EP1206542B1 (de) 2005-11-09
AU6675900A (en) 2001-03-19
CA2377730A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
EP1140840A4 (de) -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
IL136738A0 (en) Inhibition of p38 kinase activity using substituted heterocyclic ureas
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
DE69936444D1 (de) Systemische verabreichung von serum-stabilen plasmid-lipid partikeln zur krebstherapie
FI961976A0 (fi) Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina
NO326660B1 (no) Imidazolyl-cykliske acetal forbindelser, farmasøytiske sammensetninger inneholdende disse forbindelser og anvendelse av forbindelsene
ATE357509T1 (de) Stimulierung von hämatopoietischen zellen im vitro
AU2002343557A1 (en) Substituted aryl 1,4-pyrazine derivatives
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
DE69828408D1 (de) Naphthyridinone zur hemmung der durch protein-tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung
MXPA01010393A (es) Tratamiento de neoplasmas con virus.
NO20000752L (no) Metode for forhindring eller behandling av østrogen-avhengige sykdommer og forstyrrelser
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
ZA954099B (en) Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
BG103832A (en) Leptin as tumour cells proliferation inhibitor
MXPA02007899A (es) Citoquinas modificadas para utilizarse en terapia de cancer.
ZA971891B (en) Use of aryl N-substituted carboxamides directly and as radio- and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
ATE371031T1 (de) Herpes-simplex virus, das das gen von interleukin-12 exprimiert, und dessen verwendung zur behandlung von krebs
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
MXPA05004074A (es) Nuevos adenovirus, acidos nucleicos que los codifican y su uso.
DE60023915D1 (de) Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen
WO2003094967A3 (en) New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
WO2001036680A3 (en) METHODS OF PREPARING cRNA

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties